NL-OMON31603已完成2 期
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer An IKZ-based phase II feasibility study - DoCCS
Jeroen Bosch Ziekenhuis0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Ib-IVa histological proven resectable gastric adenocarcinoma, including gastro-oesophageal junction/cardia carcinoma Siewert 2 and 3
- •WHO < or equal to 1
- •Age > or equal to 18 years
- •No prior radio- or chemotherapy conflicting with the treatment of gastric cancer
排除标准
- •Ia gastric cancer
- •Other histological type than adenocarcinoma
- •Distant metastases
- •Inoperable patients
- •Previous or other current malignancies
- •Other current serious illness or medical conditions
- •Pregnant or lactating women
研究者
相似试验
进行中（未招募）
不适用
A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine combined with Protocolized Surgery in Resectable Gastric Cancer - DoCCSEUCTR2007-007273-23-NLJeroen Bosch Hospital
招募中
不适用
A study to investigate the feasibility of chemotherapy prior to surgery and protocolized surgery in resectable stomach cancer.Resectable/curable gastric cancerNL-OMON20157dr K. Bosscha, surgeondr J.F.M. Pruijt, oncologistdrs A.E. Dassen, resident in training for surgery50
招募中
2 期
eoadjuvant DOS treatment for advanced esophageal cancerEsophageal cancerJPRN-jRCTs041210023Kodera Yasuhiro45
进行中（未招募）
1 期
A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (Yondelis®) in Patients with Localized Myxoid / Round Cell Liposarcomaocalized myxoid / round cell liposarcoma previously untreated with chemotherapy or radiationMedDRA version: 9.1Level: LLTClassification code 10024630Term: Liposarcoma non-metastaticEUCTR2007-000035-25-FRPharma Mar, S.A.22
进行中（未招募）
不适用
A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (YONDELIS®) in Patients with Localized Myxoid / Round Cell Liposarcomaocally advanced (Stage III) myxoid / round cell liposarcoma previously untreated with chemotherapy or radiationMedDRA version: 9.1Level: LLTClassification code 10024630Term: Liposarcoma non-metastaticEUCTR2007-000035-25-DEPharma Mar, S.A.22